Pharyngeal carriage of Neisseria species in the African meningitis belt. by Diallo, Kanny et al.
Journal of Infection (2016) 72, 667e677www.elsevierhealth.com/journals/jinfPharyngeal carriage of Neisseria species
in the African meningitis beltKanny Diallo a,i,*, Caroline Trotter b, Youssouf Timbine a,
Boubou Tamboura a, Samba O. Sow a, Bassira Issaka c,
Ibrahim D. Dano c, Jean-Marc Collard c, Marietou Dieng d,
Aldiouma Diallo d, Adane Mihret e, Oumer A. Ali e,
Abraham Aseffa e, Stephen L. Quaye f, Akalifa Bugri f,
Isaac Osei f, Kadidja Gamougam g, Lodoum Mbainadji g,
Doumagoum M. Daugla g, Galadima Gadzama h,
Zailani B. Sambo h, Babatunji A. Omotara h, Julia S. Bennett i,
Lisa S. Rebbetts i, Eleanor R. Watkins i, Maria Nascimento j,
Arouna Woukeu j, Olivier Manigart j, Ray Borrow k,
James M. Stuart j, Brian M. Greenwood j, Martin C.J. Maiden iaCentre pour les Vaccins en De´veloppement, Bamako, Mali
bDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK
cCentre de Recherche Me´dicale et Sanitaire, Niamey, Niger
d Institut de Recherche pour le De´veloppement, Dakar, Senegal
eArmauer Hansen Research Institute, Addis Ababa, Ethiopia
fNavrongo Health Research Centre, Navrongo, Ghana
gCentre de Support en Sante´ International, N’Djamena, Chad
hUniversity of Maiduguri, Nigeria
iDepartment of Zoology, University of Oxford, Oxford, UK
j London School of Hygiene & Tropical Medicine, London, UK
kVaccine Evaluation Unit, Public Health England, Manchester, UKAccepted 16 March 2016
Available online 23 March 2016KEYWORDS
Non-meningococcal
Neisseria;* Corresponding author. Zoology Dep
865271205.
E-mail address: kanny.diallo@zoo.
http://dx.doi.org/10.1016/j.jinf.2016
0163-4453/ª 2016 The Authors. Publis
the CC BY license (http://creativecomSummary Objectives: Neisseria meningitidis, together with the non-pathogenic Neisseria
species (NPNs), are members of the complex microbiota of the human pharynx. This paper in-
vestigates the influence of NPNs on the epidemiology of meningococcal infection.artment, University of Oxford, The Tinbergen Building, S Parks Rd, Oxford, OX1 3PS, UK. Tel.: þ44 1
ox.ac.uk (K. Diallo).
.03.010
hed by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under
mons.org/licenses/by/4.0/).
668 K. Diallo et al.Pharyngeal carriage;
African meningitis beltMethods: Neisseria isolates were collected during 18 surveys conducted in six countries in the
African meningitis belt between 2010 and 2012 and characterized at the rplF locus to deter-
mine species and at the variable region of the fetA antigen gene. Prevalence and risk factors
for carriage were analyzed.
Results: A total of 4694 isolates of Neisseria were obtained from 46,034 pharyngeal swabs, a
carriage prevalence of 10.2% (95% CI, 9.8e10.5). Five Neisseria species were identified, the
most prevalent NPN being Neisseria lactamica. Six hundred and thirty-six combinations of
rplF/fetA_VR alleles were identified, each defined as a Neisseria strain type. There was an in-
verse relationship between carriage of N. meningitidis and of NPNs by age group, gender and
season, whereas carriage of both N. meningitidis and NPNs was negatively associated with a
recent history of meningococcal vaccination.
Conclusion: Variations in the prevalence of NPNs by time, place and genetic type may
contribute to the particular epidemiology of meningococcal disease in the African meningitis
belt.
ª 2016 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.
This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Introduction
The human pharynx hosts a complex microbiota, including
bacteria belonging to the genus Neisseria. Most members
of this genus are non-pathogenic commensals (non-patho-
genic Neisseria, NPNs), which very rarely cause invasive
disease, but Neisseria meningitidis (Nm), the meningo-
coccus, is an exception.1 Despite advances in vaccine
development, invasive meningococcal disease remains a
public health challenge globally and especially in the Afri-
can meningitis belt, where very large epidemics continue
to occur,2,3 despite the recent widespread deployment of
a serogroup A meningococcal conjugate vaccine (PsA-TT,
MenAfriVac).4e8
Most pharyngeal carriage studies in the African men-
ingitis belt have focused on the meningococcus,9e12 with
little attention paid to other Neisseria species apart from
Neisseria lactamica (Nl ). In northern Nigeria, pharyngeal
carriage of Nl was common, especially in young children13
and genetic exchange among Nm, Nl and unspecified Neis-
seria species has been demonstrated in The Gambia.14
Molecular epidemiological studies of Nm and Nl conduct-
ed in Burkina Faso from 2009 to 2012 reported a high over-
all prevalence of Nl carriage (18.2%), a higher prevalence
of Nl in males than in females, except in those aged
18e29 years, no change between dry and rainy season
and no significant changes following vaccination with
PsA-TT.10,15e17 It has long been considered likely that car-
riage of NPNs influences host susceptibility to infection
and invasion by Nm, a view supported by the fact that
healthy subjects inoculated with Nl exhibit some protec-
tion against colonization with Nm.18 Until recently, Nl
was considered to be the NPN genetically most similar
to Nm. However, recent whole genome sequence (WGS)
studies have shown that Neisseria polysaccharea (Np)
and Neisseria bergeri (Nb) are more closely related to
Nm than Nl.19 Consequently, these bacteria may also in-
fluence the epidemiology of Nm colonization and inva-
sion. For this reason we have studied the prevalence of
carriage with various Neisseria species in six countries
of the African meningitis belt and investigated risk factors
for their carriage.Materials and methods
The methods employed in the MenAfriCar surveys, during
which the isolates described in this paper were collected,
have been described in detail previously11 and are summa-
rized briefly here. Ethical approval for the surveys was ob-
tained from the ethics committee of the London School of
Hygiene & Tropical Medicine and from ethical committees
in each partner country. The study was registered with Clin-
icalTrials.gov (NCT01119482).
Carriage surveys
Bacteria were isolated during 18 cross-sectional surveys
conducted in Chad, Ethiopia, Ghana, Mali, Niger and Senegal
during 2010e2012 (Fig. 1). Pre-vaccination surveys in Mali,
Niger and Chad had a target of 5000 participants and post-
vaccination surveys a target of 2000 participants in Mali and
Niger and 6000 in Chad. The remaining surveys aimed to re-
cruit 2000 participants. A representative sample of house-
holds was obtained either from an updated demographic
surveillance system (DSS) or from a census conducted for
the study. Within selected households, individuals in four
different age groups (0e4 years, 5e14 years, 15e29 years
and 30 years or more) were chosen randomly until the
required sample size was reached, with a maximum of 5 indi-
viduals recruited per household. Once written consent had
been obtained, standardized household and individual ques-
tionnaires inquiring about risk factors for meningococcal
infection were administered. Pharyngeal swabs were ob-
tained using a standardized technique that involved swabbing
both the posterior-pharyngeal wall and the tonsils.20
Bacteriology
NPNs were isolated using the same conventional microbi-
ology techniques that were employed for the detection of
Nm described previously.11 Briefly, pharyngeal swabs were
plated onto modified Thayer Martin agar plates and incu-
bated 24e48 h at 37 C in 5% CO2; oxidase and gram stain
testing identified oxidase positive, Gram-negative
Figure 1 Frequency distribution of Neisseria species in each country of the study.
Carriage of non-meningococcal Neisseria 669diplococci. Further biochemical tests (ortho-nitrophenyl-b-
galactoside, ץ-glutamyl transpeptidase and tributyrin) were
used in each site to differentiate between putative Nl and
Nm isolates and members of the genus Moraxella.
Molecular methods
A boiled cells suspension of each oxidase positive, Gram
negative diplococci (OPGND) isolate was sent to the
Department of Zoology at the University of Oxford for
molecular typing, where Sanger sequencing was used to
characterize gene targets as described in the Supplement.
Sequences were assembled using SeqSphere (http://www.
ridom.de/seqsphere/) and imported into the isolate’s re-
cord previously created in a BIGSdb database.21
Neisseria speciation
Amplification and sequencing of a 413 bp fragment of the
rplF gene was used to differentiate among Neisseria species
as described previously.22 A phylogeny based on the f_rplF
alleles from Bennett et al. (2014) and the unique alleles
found in this study was reconstructed using the Neighbor-
Joining algorithm23 and the Kimura 2-parameter substitu-
tion model24 in MEGA version 6.0.25 For isolates that did not
yield results for the rplF assay, sequencing of the rrna
gene, encoding 16S rRNA,26 was used to confirm the pres-
ence or absence of a bacterium and to determine its genus.
Only rplF confirmed NPNs were included in this study with
the exception of four Nm speciated on the basis of the
16S rRNA and the porA sequences. New alleles were inves-
tigated by a BLAST of obtained sequences against the 16SrRNA sequence data of the EzTaxon server (http://www.
ezbiocloud.net/eztaxon;27).
Genetic diversity
Sequencing of the variable region of the fetA gene (feta_VR)
was used to assess the genetic diversity of the Neisseria
identified as described in the Supplementary methods.28
The sequences were assembled as for the other targets using
SeqSphere (http://www.ridom.de/seqsphere/). The trace
files of each new allele were manually curated in MEGA
version 6.0,25 the quality of the sequences were assessed
and the modified bases checked in both the forward and
reverse trace file. The corresponding protein sequences
were also aligned and compared with known sequences
stored in the Neisseria sequence definition database of
pubMLST21 before being entered into the allele database
and the appropriate isolate record.
For isolates for which fetA_VR could not be amplified, an
assay identifying the absence of the fetA gene (fetA null,
fnl ) was employed, using primers placed on genes on
each side of the fetA gene: thdF and fetB as described in
the Supplementary methods.29
Statistical methods
Analyzes were performed using Stata v12.0 (StataCorp,
Texas). Survey design and potential household clustering
were taken into account using the survey commands in
Stata. Carriage prevalence of each of the different Neisse-
ria species, together with 95% confidence intervals, was
calculated for each country and each survey. Risk factors
670 K. Diallo et al.for carriage of Nm and NPNs were assessed simultaneously
using multinomial logistic regression. Each risk factor was
considered in turn using univariable, multinomial logistic
regression. A multivariable model was then constructed
including country, age group and sex a priori and any vari-
able with a p-value <0.1 in the univariable analyses; only
the variables with a p value < 0.05 in the multivariable
analysis were kept in the final model. As a final check, drop-
ped variables were re-entered into the model one at a time
and the p-values re-examined; the variable was retained as
significant if the p value was <0.05.
Results
Prevalence of carriage with Neisseria species
A total of 4694 of the 46034 pharyngeal swabs collected
yielded a Neisseria species, giving a carriage prevalence of
10.2% [95% CI, 9.8e10.5%]: 696 Neisseria were identified
out of the 946 OPGND samples received from Chad; 838Table 1 Factors associated with carriage of Neisseria meningit
multivariable logistic regression.
Factor Numb
(carri
Age <1 year 207
1e4 years 829
5e14 years 12,56
15e29 years 11,86
30 þ years 11,24
Sexa Female 26,61
Male 19,29
Season Rainy (XS1 and XS2) 30,52
Dry (XS3) 15,51
Country Chad 13,39
Ethiopia 597
Ghana 520
Mali 883
Niger 821
Senegal 440
Area Urban 19,46
Rural 26,57
Crowdingb <2 people per room 16,29
2 people per room 29,67
Kitchen location Open air 17,80
Inside house 12,74
Separate hut 1492
Missing information 50
Vaccinated recently
with meningitis vaccine
No 31,33
Yes, <1 year ago 904
Yes, 1e3 years ago 454
Don’t know/missing 102
The final multivariable logistic regression model included age group,
vaccination.
Other risk factors used in the univariable model but not significant in t
ing fuel, respiratory symptoms and attendance of social gatherings.
a Sex not reported for 119 individuals.
b Data not reported for 57 individuals.out of the 994 received from Ethiopia; 446 out of the 544
received from Ghana; 298 out of the 504 from Mali; 1644
out of 2321 from Niger and 773 out of the 971 received
from Senegal. The most frequently isolated species was Nl
with a 5.6% point prevalence [95% CI, 5.3e5.8%], followed
by Nm at 3.6% [95% CI, 3.4e3.8%]), Np at 0.6% [95% CI,
0.5e0.7%], Nb at 0.2% [95% CI, 0.2e0.3%] and Neisseria sub-
flava (Ns) at 0.05% [95% CI, 0.03e0.1%] (Supplementary
Table 1). Twenty isolates from Chad were identified as
belonging to the Neisseria genus but did not cluster with
any known species on the Neighbor-Joining Tree (NJT; data
not shown); they were designated Neisseria sp. and will be
investigated further by whole genome sequencing methods.
Factors influencing the prevalence of carried
Neisseria species
Country, season, age, gender, and a history of recent
vaccination against Nm were associated with carriage of
NPNs. Additionally, area of residence, household crowdingidis and non-pathogenic Neisseria; results from a multinomial
er
ers)
Adjusted RRR
Neisseria meningitidis
(95% CI)
Adjusted RRR
Non-pathogenic
Neisseria (95% CI)
4 (207) 0.40 (0.29, 0.55) 3.11 (2.60, 3.73)
1 (1355) 0.70 (0.59, 0.82) 5.90 (5.23, 6.65)
3 (895) 1.49 (1.31, 1.69) 2.59 (2.29, 2.94)
3 (4372) 1.0 1.0
3 (206) 0.59 (0.50, 0.68) 0.51 (0.43, 0.61)
9 (1701) 1.0 1.0
6 (1313) 1.34 (1.21, 1.48) 0.87 (0.80, 0.94)
2 (220) 1.0 1.0
2 (815) 1.53 (1.35, 1.74) 0.78 (0.70, 0.86)
6 (584) 1.0 1.0
0 (450) 7.11 (5.43, 9.29) 1.70 (1.44, 2.01)
9 (253) 4.81 (3.64, 6.35) 1.25 (1.03, 1.51)
7 (219) 1.45 (1.05, 1.99) 0.48 (0.40, 0.58)
3 (1112) 11.39 (9.00, 14.43) 3.58 (3.13, 4.01)
9 (427) 10.85 (8.28, 14.23) 2.39 (1.97, 2.89)
2 (1398) 1.0 1.0
2 (1637) 1.44 (1.09, 1.60) 0.97 (0.88, 1.06)
9 (889) 1.0 1.0
9 (2127) 1.27 (1.12, 1.45) 1.08 (0.98, 1.19)
5 (1274) 1.0 1.0
1 (1027) 1.32 (1.09, 1.60) 0.90 (0.79, 1.02)
7 (677) 0.94 (0.76, 1.17) 0.96 (0.84, 1.09)
4 (38) 1.06 (0.57, 1.98) 0.77 (0.51, 1.17)
8 (2060) 1.0 1.0
8 (545) 0.71 (0.59, 0.84) 0.82 (0.73, 0.92)
3 (356) 0.51 (0.42, 0.63) 0.94 (0.81, 1.10)
0 (55) 0.68 (0.47, 1.00) 0.62 (0.46, 0.84)
sex, country, season area, crowding, kitchen location and recent
he adjusted model: smoking, living in a house with smokers, cook-
T
a
b
le
2
N
u
m
b
e
r
o
f
is
o
la
te
s
id
e
n
ti
fi
e
d
a
s
a
N
e
is
se
ri
a
sp
e
ci
e
s
p
e
r
su
rv
e
y.
N
.
m
e
n
in
gi
ti
d
is
P
re
va
le
n
ce
[C
I]
N
.
la
ct
a
m
ic
a
P
re
va
le
n
ce
[C
I]
N
.
p
o
ly
sa
cc
h
a
re
a
P
re
va
le
n
ce
[C
I]
N
.
b
e
rg
e
ri
P
re
va
le
n
ce
[C
I]
N
.
su
b
fl
a
va
P
re
va
le
n
ce
[C
I]
T
o
ta
l
P
re
va
le
n
ce
[C
I]
Su
rv
e
y
1
57
7
3.
6
[3
.3
e
3.
9]
89
6
5.
7
[5
.3
e
6.
1]
79
0.
5
[0
.4
e
0.
6]
17
0.
1
[0
.1
e
0.
2]
4
0.
03
[0
e
0.
05
]
15
73
10
.0
[9
.4
e
10
.5
]
Su
rv
e
y
2
45
4
3.
0
[2
.7
e
3.
3]
10
10
6.
7
[6
.3
e
7.
2]
11
7
0.
8
[0
.6
2
e
0.
9]
62
0.
4
[0
.3
e
0.
5]
17
0.
1
[0
.1
e
0.
2]
16
60
11
.1
[1
0.
6e
11
.7
]
Su
rv
e
y
3
64
8
4.
2
[3
.8
e
4.
5]
68
2
4.
4
[4
.0
e
4.
7]
94
0.
6
[0
.5
e
0.
7]
34
0.
2
[0
.1
e
0.
3]
3
0.
02
[
0.
00
2
to
0.
04
]
14
61
9.
41
[8
.9
e
9.
9]
T
o
ta
l
1
6
7
9
3
.6
[3
.4
e
3
.8
]
2
5
8
8
5
.6
[5
.3
e
5
.8
]
2
9
0
0
.6
3
[0
.5
e
0
.7
]
1
1
3
0
.2
[0
.2
e
0
.3
]
2
4
0
.0
5
[0
.0
3
e
0
.1
]
4
6
9
4
1
0
.2
[9
.8
e
1
0
.5
]
Carriage of non-meningococcal Neisseria 671and kitchen location were significant risk factors for car-
riage of Nm (Table 1).
Country: The prevalence of carriage of Neisseria spe-
cies overall varied significantly among countries with Niger
having the highest point prevalence (19.9% [95% CI,
18.9e20.9]), followed by Senegal (17.5% [95% CI,
16.1e18.8]), Ethiopia (13.8% [95% CI, 12.8e14.8]), Ghana
(8.5%[95% CI, 7.6e9.4]), Chad (5.3%[95% CI, 4.9e5.7])
and Mali (3.4% [95% CI, 2.9e3.8]) (Supplementary
Table 1). The distribution of the different species of Neis-
seria by country is shown in Fig. 1. The prevalence of Nm
carriage varied significantly among countries, being high-
est in Senegal (8.0% [95% CI, 7.1e9.0]) and lowest in Mali
(0.9% [95% CI, 0.7e1.1]). There were also major differ-
ences in the prevalence of carriage of NPNs by country
and some NPNs were not identified in some countries,
for example no Nb were isolated in Ethiopia and Senegal
and no Ns in Ghana. Ethiopia was the only country where
the prevalence of Nm carriage was higher than that of Nl.
Year and season: The prevalence of carriage of Neisse-
ria species overall varied little over the three years of the
study: 10.0% [95% CI, 9.4e10.5%] in the first survey, 11.1%
[95% CI, 10.6e11.7%] in the second survey and 9.4% [95%
CI, 8.9e9.9%] in the third survey (Table 2). The prevalence
of carriage with both Nm and NPNs was also similar over
time, with Nl being the most carried species, regardless
of survey or season. There was, however, variation in
the prevalence of carriage of NPNs over time at the coun-
try level: for example, there was an increase in the prev-
alence of Nl between surveys 1 and 2 in both Chad (from
1.1% to 5.9%) and Ghana (from 0.8% to 6.3%) and an in-
crease in Nm prevalence between survey 2 and 3 in
Senegal (from 3.1% to 19.8%4) (Supplementary Fig. 1).
The relative risk of carriage of NPNs was significantly
lower during the dry compared to the rainy season with
an adjusted Relative Risk Ratio (aRRR) of 0.78, [95% CI,
0.70e0.86], whereas the opposite was true for Nm with
an aRRR of 1.53, [95% CI, 1.35e1.74] in the dry season.
Age and gender: The relative risk of carrying NPNs overall
was higher in children aged less than 15 years compared to
the young adult age group (age 15e29 years) with an aRRR
of 3.11 [95% CI, 2.60e3.73] for those <1 year, 5.90 [95% CI,
5.23e6.65] for the 1e4 year olds and 2.59 (95% CI,
2.29e2.94) for the 5e14 year olds. The oldest age group
>30 years had a lower aRRR of 0.51 (95% CI, 0.43e0.61).
The prevalence of carried Nl was highest in the 1e4 year
old age group, reaching a peak of 14.1% [95% CI,
13.3e14.8%] in contrast to carriage of Nm, which reached a
peak of 5.2% [95% CI, 4.8e5.6%] in the 5e14 year age group.
Similarly toNl, Np carriage also reached a peak prevalence of
1.7% [95%CI, 1.4e1.9%] in the 1e4 year old age group (Fig. 2).
Carriage prevalence of Nb and Ns was too low to identify an
overall trend in age group distribution. Males had a lower
risk of carrying NPNs than females (aRRR of 0.87 [95% CI,
0.80e0.94]) but a higher risk of carrying Nm (aRRR of 1.34
[95% CI, 1.21e1.48].
Vaccination history: A history of vaccination within the
past 12 months with any meningococcal vaccine was asso-
ciated with a decrease in Nm carriage, as reported previ-
ously,8 but additionally with a decreased risk of carrying
NPNs (aRRR of 0.82 [95% CI, 0.73e0.92]. In the three coun-
tries where MenAfriVac was introduced during the course
Figure 2 Prevalence ofNeisseria species carried by age group.
672 K. Diallo et al.of the study (Chad, Mali, and Niger) a significant decrease
in the prevalence of carriage of Nl from 6.4% to 4.9% was
observed. An overall decrease in carriage of Nm was also
observed in the three countries but this reduction was not
consistent in all countries with Mali experiencing an in-
crease from 0.6% to 1.2% (Supplementary Fig. 2).
Other risk factors: Area of residence (rural vs urban),
crowding, cooking with cow dung or straw, kitchen location,
and attendance at social gatherings in the past week all had
a significant impact on the odds of carrying NPNs in the uni-
variable regression model, but their effect was not signifi-
cant in the multivariable model. Some of these risk factors
were retained in the final model as, although they had no ef-
fect on NPN carriage, they were significant for Nm carriage.
Genetic diversity of identified Neisseria species
Forty-two different alleles were identified for the rplf frag-
ment (f_rplf ). Nl was the most diverse species with 17
f_rplf alleles, the most frequent of which was f_rplf 6
(1453 isolates, 56.1%). Eleven alleles were found for Nm
the most frequent being f_rplf 2 (749 isolates, 44.6%) and
f_rplf 1 (707 isolates, 42.1%); four f_rplf alleles were iden-
tified in Np, the most frequent of which was f_rplf 9 (207
isolates, 71.4%). Four alleles were also found among the
Nb alleles with f_rplf 62 (57) and f_rplf 69 (46) representing
91.2% of these isolates. Finally, seven alleles were observed
for Ns, with predominance of f_rplf 43 (15 isolates, 62.5%)
(Supplementary Table 2). A Neighbor Joining tree was used
to represent the phylogeny of the rplF fragment present in
the Neisseria isolates of this study in relation to the original
isolates used to create the f_rplF assay22 (Supplementary
Fig. 3).
The diversity of fetA alleles varied by country (Fig. 3A;
Supplementary Table 3); Niger had the highest number of
fetA_vr alleles (111) and Ghana had the least (55). Some
allele variability was seen between surveys, for example
the proportion of the F1-1 allele increased from 61
(3.63%) in survey 2 to 342 (23.38%) in survey 3 and similar
changes were observed for others alleles in survey 3
(Fig. 3B; Supplementary Table 4). A total of 234 different
alleles were identified across all species: 75 of these were
found in only one isolate; 184 in fewer than 20 isolates. Atotal of 194 alleles were observed for Nl, 80 for Nm; 35
for Np; 21 for Nb; and 16 for Ns. Most alleles were found
predominantly in only one species, for example 99.61% of
fnl alleles were found in Nm,29,30 all F5-84 variants were
only detected in Nl, all F5-1 were exclusive to Nm, all
F11-4 were found only in Np and all F1-169 and all F1-193
variants were only observed in Ns. Some variants, however,
were shared among different species, e.g. F1-72, F1-21, F2-
24, F6-3 (Fig. 3C; Supplementary Table 5). Neither the fe-
tA_VR nor the fnl fragment was successfully amplified in
643 isolates, which were designated Not Determined (ND).
As defined by f_rplf and feta_VR alleles, there were 636
different Neisseria strain types identified, with almost
half of these (297, 46.70%) observed only once. There was
appreciable variation in the frequency of the strain types
observed more than 20 times (Table 3).Discussion
Although the introduction of PsA-TT into the African men-
ingitis belt has had a major impact on serogroup A
epidemics,8,31 the region will remain at risk of meningo-
coccal disease until comprehensive vaccines targeting all
serogroups are available.3 The reasons for the unique
epidemiology of the African meningitis belt remain poorly
understood,32 making it difficult to predict when and where
epidemics caused by non-serogroup A meningococci might
occur. Variations in the prevalence of NPN species, which
potentially contribute cross immunity through sub-
capsular antigens, could play a role in determining suscep-
tibility to a potentially epidemic strain. A number of studies
have indicated the movements of genes encoding various
protein antigens from NPN to Nm14,33 and variants of the
FetA antigen have been previously shown to be shared
amongst Neisseria species.14,34 This antigen is known to
generate protective responses in humans.35 Colonization
with NPNs also affects colonization of humans in experi-
mental studies.18
The novel sequence based techniques employed in this
study enabled Nm and NPN to be identified and character-
ized rapidly and cost effectively from the very large
numbers of samples obtained in the African centers. The
rplF assay22 achieved reliable speciation, which would not
have been possible with conventional methods such as
16S rRNA gene sequencing. An indication of diversity within
species was achieved by sequencing the variable region of
the gene encoding FetA (fetA_VR), an outer membrane pro-
tein (OMP) found in most Neisseria, and which is involved in
iron metabolism and been shown to elicit protective im-
mune responses.36 Further characterization of the menin-
gococcal isolates has been previously published.12
Of the five known Neisseria species identified, with a
possible novel species present in Chad, the most common
were Nl and Nm. These are the species that have been
observed mostly frequently in previous investigations in
the African meningitis belt and they are known to have
antagonistic interactions in colonization.18,37 It is possible
that the isolation of some of the other species was affected
by the selective media used in this and other studies.
Although growth of Np,38 Nl17,39e41 and Ns42 on colistin con-
taining agar (such as modified ThayereMartin or New York
Figure 3 Frequency distribution of fetA_VR alleles. Frequency distribution of different alleles of the variable region of fetA.
Only the 10 most common alleles are displayed; distribution by country (A), by survey (B) and by species (C).
Carriage of non-meningococcal Neisseria 673city medium) has been reported, other species such as Neis-
seria perflava, Neisseria sicca, Neisseria mucosa, Neisseria
cinerea may not have been identified using the culture
technique employed in this study.43 The impact of these
media on Nb is unknown. In future, the identification of
NPNs could be enhanced by the use of molecular ap-
proaches, although these will have to have species-level
resolution, such as the rplF assay.22 The Neisseria identified
were highly diverse at both the strain and the species level
and varied markedly over time and place. This is consistent
with other carriage studies in the meningitis belt, but is
different from the relatively stable carriage observed in
countries that do not experience large-scale epidemic
disease.44
The most common NPNs recovered, Np and Nl, were iso-
lated predominantly from young children as opposed to Nm,
which was isolated most frequently from older children. Nlis known to colonize infants and young children preferen-
tially in many settings45 and this is consistent with carriage
of NPNs having a role in the rapid acquisition of antibody
against Nm among children in the meningitis belt, although
given the age distribution of meningococcal disease these
antibodies may not be protective.46
The risk factors for Nm and NPNs carriage were not the
same and in some cases (eg. age, sex and season) were
inversely related. Individuals were more likely to carry
NPNs during the rainy season if they were a female and
under 5 years old whereas they were more likely to carry
Nm during the dry season, if they were male and between 5
and 29 years old.12 These results suggest that the physical
presence of an NPN in the pharynx may prevent the coloni-
zation by Nm although this may not apply to the hyper-
invasive meningococci since the incidence of meningo-
coccal disease in the African meningitis belt is highest in
674 K. Diallo et al.under five year olds. Recent vaccination with a meningitis
vaccine (primarily MenAfriVac, which was used in Mali,
Niger and Chad during the course of our study) appeared
to be protective both against carriage of Nm and NPNs over-
all in the regression analysis. This effect could possibly be
explained by disturbance of the microbiome following
vaccination but could also be due to residual confoundingTable 3 Number of isolates for the most common commensal s
Commensal strain_type
“f_ rplf:fetA”
Neisseria bergeri Neisseria lacta
1:fnl e e
2:F1-1 e e
6:F1-31 e 205
2:F5-1 e e
6:ND e 122
32:ND e 88
52:ND e 82
2:F1-3 e e
1:ND e e
9:ND e e
6:F1-29 e 62
34:F1-62 e 56
6:F1-62 e 47
52:F3-60 e 46
6:F1-100 e 46
6:F1-72 e 46
1:F3-1 e e
6:F5-133 e 45
6:F4-5 e 43
6:F4-17 e 42
9:F7-3 e e
6:F5-84 e 36
33:F2-17 e 35
52:F1-21 e 35
62:ND 35 e
33:ND e 34
88:fnl e e
9:F2-24 e e
1:F5-5 e e
34:ND e 31
69:ND 31 e
6:F4-6 e 29
6:F5-12 e 29
2:ND e e
6:F5-18 e 26
2:F6-3 e e
52:F1-29 e 25
6:F1-21 e 25
9:F11-4 e e
4:F1-7 e e
63:F1-72 e e
6:F6-2 e 23
1:F4-23 e e
33:F4-6 e 22
33:F5-34 e 22
6:F2-23 e 22
6:F1-120 e 21
6:F1-101 e 20or a reflection of the naturally dynamic patterns of car-
riage. In Mali, an increase in Nm was observed post-
vaccination, due to an expansion of serogroup W.12 This
seems unlikely to be an effect of MenAfriVac but it is
not known how the removal of one serogroup from the
nasopharyngeal environment could affect the other se-
rogroups. The influence of host factors on carriage of Nmtrain types per species.
mica Neisseria meningitidis Neisseria
polysaccharea
Total
470 e 470
452 e 452
e e 205
135 e 135
e e 122
e e 88
0 e 82
74 e 74
68 e 68
e 66 66
e e 62
e e 56
e e 47
e e 46
e e 46
e e 46
45 e 45
e e 45
e e 43
e e 42
e 37 37
e e 36
e e 35
e e 35
e e 35
e e 34
32 e 32
e 32 32
31 e 31
e e 31
e e 31
e e 29
e e 29
28 e 28
e e 26
25 e 25
e e 25
e e 25
e 25 25
23 e 23
e 23 23
e e 23
22 e 22
e e 22
e e 22
e e 22
e e 21
e e 20
Carriage of non-meningococcal Neisseria 675and NPNs has not been investigated in this study but the IgA
secretory status of the individuals sampled could also play a
role as previously shown.47
Few published studies have characterized pharyngeal
NPNs in the African meningitis belt. One recent study in
Burkina Faso, which did not survey adults over the age of 30
years or identify species other than Nm and Nl,17 reported a
number of differences compared to the MenAfriCar surveys
described here: there was a higher overall prevalence of Nl
carriage (18.2%); a higher prevalence in males, although it
was significantly higher in women (9.1% vs 3.9%) for the
18e29 year age group and no significant changes between
seasons or post vaccination. The reasons for these inconsis-
tencies are unclear, although both studies indicated fluctu-
ations in prevalence among surveys and these differences
may reflect the highly dynamic nature of Neisseria
carriage.
Some of the fetA_VR alleles found were shared among
the different species, as reported previously.14,34 Since
the variable region of fetA plays an important role in its
immunogenicity,28 the shared protein variants could create
a cross-reactive immunity at the subscapular level. The in-
clusion of fetA_VR in the meningococcal typing system also
increased discrimination between strains (supplemental
Table 6). Although there was correlation between porA
and fetA_VR alleles for some Nm strains (e.g. cnl:P1.18-
11,42-1:fnl ), in others the fetA_VR (e.g. W:P1.5,2:F1-1
and W:P1.5,2:F6-3) or both OMPs (e.g. W:P15-1,2-36:F5-1)
sequences varied, suggesting that the serogroup W Nm
strains are antigenically diverse. This has potential implica-
tions for using proteins such as porA or fetA in vaccine for-
mulations.48 The Neighbor Joining phylogeny (Supplemental
Fig. 3) shows the clustering of all of the isolates with the
appropriate species except for one, which has the f_rplF
allele 58 defined previously as Ns22 but clusters more
closely, in this study, with the Nb species which was not
discovered at the time of the previous study. This particular
isolate may also be a Ns with a f_rplF allele similar to Nb.
More sequence data from this isolate will clarify this issue.
This study has demonstrated the dynamic nature and
high diversity of the genus Neisseria in pharyngeal carriage
in countries of the African meningitis belt. The results are
consistent with the idea that the carriage of NPNs may in-
fluence invasive meningococcal disease epidemiology in
the African meningitis belt. Although more research is
needed to elucidate such effects, understanding these or-
ganisms could potentially contribute to meningococcal dis-
ease control. This is of particular importance given the
absence of comprehensive vaccines against all meningo-
coccal serogroups and the continuing interest in the devel-
opment of protein based vaccines.Financial support
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